Cytokine expression by first-trimester human chorionic villi

American Journal of Reproductive Immunology

Volumn 40, Issue 5, 1998, Pages 309-318

  Bennett, W A ^a   Lagoo Deenadayalan, S ^a   Stopple, J A ^b   Barber, W H ^a   Hale, E ^a   Brackin, M N ^a   Cowan, B D ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

Cytokines; Growth factor; Immunotolerance; Messenger ribonucleic acid; Placenta; Pregnancy

Indexed keywords

ALPHA INTERFERON; BETA ACTIN; BETA INTERFERON; CYTOKINE; GAMMA INTERFERON; GUANIDINE DERIVATIVE; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; PHENOL; RNA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CHORION VILLUS; CLINICAL ARTICLE; FEMALE; FIRST TRIMESTER PREGNANCY; HOUSEKEEPING GENE; HUMAN; HUMAN TISSUE; INDUCED ABORTION; LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0031774740     PISSN: 10467408     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0897.1998.tb00059.x     Document Type: Article

References (66)

1. Stewart CL, Kaspar P, Brunet LJ, Bhatt H, Gadi I, Kontgen F, Abbondanzo SJ: Blastocyst implantation depends on maternal expression of leukemia inhibitory factor. Nature 1992; 359:76-79.
2. Librach CL, Feigenbaum SL, Bass KE, Cui TY, Verastas N, Sadorvsky Y, et al.: Interleukin-1 beta regulates human cytotrophoblast metalloproteinase activity and invasion in vitro. J Biol Chem 1994; 269:17125-17131.
3. Drake BL, Head JR: GM-CSF and CSF-1 stimulate DNA synthesis but not cell proliferation in short-term cultures of mid-gestational murine trophoblast. J Reprod Immunol 1994; 26:41-56.
4. Ohlsson R: Growth factors, protooncogenes and human placental development. Cell Differ Dev 1989; 28:1-6.
5. Ohlsson R, Holmgren L, Glaser A, Szpecht A, Pfeifer-Ohlsson S: Insulin-like growth factor 2 and short-range stimulatory loops in control of human placental growth. EMBO J 1989;8:1993-1999.
6. H2 phenomenon. Immunol Today 1993; 14:353-355.
7. Lin H, Mossmann TR, Guilbert L, Tuntipopipat S, Wegmann TG: Synthesis of T helper 2-type cytokines at the maternal-fetal interface. J Immunol 1993; 151:4562-4573.
8. Aboagye-Mathiesen G, Toth FD, Zdravkovic M, Ebbesen P: Functional characteristics of human trophoblast interferons. Am J Reprod Immunol 1996; 35:309-317.
9. Clark DA, Flanders KC, Banwatt DK, et al.: Murine pregnancy decidua produces a unique immunosuppressive molecule related to transforming growth factor β-2. J Immunol 1990;144:3008-3014.
10. Howard M, O'Garra A, Ishida H, De Waal Malefyt R, de Vries J: Biological properties of interleukin 10. J Clin Immunol 1992; 12:239-247.
11. Casey ML, Cox SM, Butler B, Milewich L, MacDonald PC: Cachetin tumor necrosis factor-alpha formation in human decidua: Potential role ofcytokines in infection-induced preterm labor. J Clin Invest 1989; 83:430-436.
12. Baergen R, Benirschke K, Ulich TR: Cytokine expression in the placenta. The role of interleukin 1 and interleukin 1 receptor antagonist expression in chorioamnionitis and par-turition. Arch Pathol Lab Med 1994; 118:52-55.
13. Cross JC. Trophoblast function in normal and preeclamptic pregnancy. Fetal Maternal Med Rev 1996; 8:57-66.
14. Vince GS, Starkey PM, Austgalen R, Kwiatkouski D, Redman CWG: Interluekin-6, tumor necrosis factor, and soluble tumor necrosis factor receptors in women with preeclampsia. Br J Obstet Gynaecol 1995; 102:20-25.
15. Hara H, Fuku T, Okai T, Yui T: Histochemical demonstration of interleukin-2 in decidual cells of patients with preeclampsia. Am J Reprod Immunol 1995; 34:44-51.
16. Raghupathy R, Tangri S: Immunodystrophism, T cells, cytokines and pregnancy failure. Am J Reprod Immunol 1996; 35:291-296.
17. Tangri S, Raghupathy R: Expression of cytokines in placentas of mice undergoing immunologically-mediated spontaneous fetal resorption. Biol Reprod 1993; 49:850-857.
18. H2 cytokines at the maternal-fetal interface. J Immunol 1994; 151:4562-4573.
19. Chaouat G, Meliani AA, Martal J, Raghupathy R, Elliot J, Mosmann T, et al.: IL-10 prevents naturally occurring fetal loss in the CBA × DBA/2 mating combination, and local defect in IL-10 production in this abortion-prone combination is corrected by in-vitro injection of IFN-τ. J Immunol 1995; 154:4261-4268.
20. Bennett WA, Lagoo-Deenadayalan S, Brackin MN, Hale E, Cowan BD: Cytokine expression by models of human trophoblast as assessed by a semiquantitative reverse transcription-polymerase chain reaction technique. Am J Reprod Immunol 1996; 36:285-294.
21. Lagoo-Deenadayalan S, Lagoo AS, Barber WH, Hardy KJ: A standardized approach to PCR-based semiquantitation of mutlitple cytokine gene transcripts from small cell samples. Lymphokine Cytokine Res 1993; 12:59-67.
22. Lebon P, Girard S, Thepot F, Chany C: The presence of γ-interferon in human amniotic fluid. J Gen Virol 1982; 59:393-396.
23. Howatson AG, Farquharson M, Meager A, McNicol AM, Foalis AK: Localization of α-interferon in the human fetoplacental unit. J Endocrinol 1988; 119:531-534.
24. Duc-Goron P, Robert-Galliot B, Lopez J, Chany C: Unusual apparently constitutive interferons and antagonists in human placental blood. Proc Natl Acad Sci USA. 1985; 82:5010-5014.
25. Bulmer JN, Morrison L, Johnson PM, Meager JA: Immunohistochemical localization of interferons in human placental tissues in normal, ectopic, and molar pregnancy. Am J Reprod Immunol 1990; 22:109-116.
26. Aboagye-Mathiesen G, Toth FD, Petersen PM, Gildberg A, Norskov-Lauritsen N, et al.: Differential interferon production in human first and third trimester trophoblast cultures stimulated with viruses. Placenta 1993; 14:225-234.
27. Aboagye-Mathiesen G, Toth FD, Dalsgaard AM, Petersen PM, Zacher V, et al.: Characterization of Sendai virus-induced human placental trophoblast interferons. J Gen Virol 1991; 72:1871-1876.
28. Bourinbaiar AS, Krasinski K, Borkowsky W, Lee-Huang S: Protective effect of interferon-alpha against cell-mediated human immunodeficiency virus transmission resulting from coculture of infected lymphocytes with fetal trophoblasts. J Interferon Cytokine Res 1995; 15:503-508.
29. Zdravkovic M, Aboagye-Mathiesen G, Zachar V, Toth FD, Dalsgard AM, et al.: Immunosuppressive effects of human placental trophoblast interferon-β on lymphocytes in-vitro. Placenta 1994; 15:591-600.
30. Bennett WA, Brackin MN, Long CA, Cowan BD: Immunosuppression by hydatidiform mole trophoblast is neutralized by monoclonal antibodies to β-interferon. Am J Reprod Immunol 1994; 32:157-162.
31. Hager H, Aboagye-Mathiesen G, Petersen PM, Norskov-Lauritsen N, Juhl CB, Villadsen JA, et al.: Human trophoblast interferons enhance major histocompatibility complex class I antigen expression on human term trophoblast cells in culture. Placenta 1994; 15:709-714.
32. Cadet P, Rody PL, Tyring SK, Yandell RB, Hughes TK: Interluekin-10 messenger ribonucleic acid in human placenta: Implications of a role for interleukin-10 in fetal allograft protection. Am J Obstet Gynecol 1995; 173:25-29.
33. Roth I, Corry DB, Locksley RM, Abrahms JS, Litton MJ, Fisher SJ: Human placental cytotrophoblasts produce the immunosuppressive cytokine interleukin 10. J Exp Med 1996; 184:539-548.
34. Bennett WA, Lagoo-Deenadayalan S, Whitworth NS, Brackin MN, Barber WH, Hale E, Cowan BD: Expression and production of interleukin-10 by human trophoblast: relationship to pregnancy immunotolerance. Early Pregnancy: Biology and Medicine (in press).
35. Lysiak JJ, Hunt J, Pringle GA, Lala PK: Localization of transforming growth factor beta and its natural inhibitor decorin in the human placenta and decidua throughout gestation. Placenta 1995; 16:221-231.
36. Selick CE, Horowitz GM, Gratch M, Scott RT Jr, Navot D, Hofmann GE: Immunohistochemical localization of transforming growth factor-beta in human implantation sites. J Clin Endocrinol Metab 1994; 78:592-596.
37. Graham CH. Effect of transforming growth factor-beta on the plasminogen activator system in cultured first trimester human cytotrophoblasts. Placenta 1997; 18:137-143.
38. Song Y, Keelan J, France JT. Activin-A stimulates, while transforming growth factor beta 1 inhibits, chorionic gonadotropin production and aromataseactivity in cultured human placental trophoblasts. Placenta 1996; 17:603-610.
39. Hamlin GP, Soares MJ. Regulation of deoxyribonucleic acid synthesis in proliferating and differentiating trophoblast cells: Involvement of transferrin, transforming growth factor-beta, and tyrosine kinases. Endocrinology 1995; 136:322-331.
40. Clark DA, Vince G, Flanders KC, Hirte H, Starkey P. CD56+ lymphoid cells in human first trimester pregnancy decidua as a source of novel transforming growth factor-2-related immunosuppressive factors. Hum Reprod 1994; 9:2270-2277.
41. Kauma SW, Herman K, Wang Y, Walsh SW: Differential mRNA expression and production of interleukin-6 in placental trophoblast and villous core compartments. Am J Reprod Immunol 1993; 30:131-135.
42. Neki R, Matsuzaki N, Yamanaka K, Shimoya K, Okada T, Saji F, et al.: The interleukin-6 (IL-6)/IL-6-receptor system induces human chorionic gonadotropin production by activating tyrosine kinase-dependent signal transduction pathway different from pathways triggered by protein kinase activators including gonadotropin releasing hormone. J Clin Endocrinol Metab 1993; 17:704-709.
43. Romero R, Yoon BH, Kenney JS, Romex R, Allison AC, Sehgal PB: Amniotic fluid interleukin-6 determinations are of diagnostic and prognostic value in preterm labor. Am J Reprod Immunol 1993; 30:167-183.
44. Negishi H, Yamada H, Mikuni M, Kishida T, Okuyama K, Sagawa T, et al.: Correlation between cytokine levels of amniotic fluid and histological chorioamnionitis in preterm delivery. J Perinatol Med 1996; 24:633-639.
45. Steinborn A, Kuhnert M, Halberstadt E: Immunomodulating cytokines induce term and preterm parturition. J Perinatal Med 1996; 24:381-390.
46. Kauma SW, Turner TT, Harty JR: Interleukin-1β stimulates interleukin-6 production in placental villous core mesenchymal cells. Endocrinology 1994; 134:457-460.
47. Chernicky CL, Tan H, Burfeind P, Ilan J, Ilan J: Sequence of interleukin-2 isolated from human placental poly A+RNA:possible role inmaintenance of the fetal allograft. Mol Reprod Dev 1996; 43:180-186.
48. Saito S, Morii T, Enomoto M, Sakakura S, Nishikawa K, Narita N, et al.: The effect of interleukin-2 and transforming growth factor-beta 2 (TGF-beta2) on the proliferation and natural killer activity of decidual CD16-CD56 bright natural killer cells. Cell Immunol 1993; 152:605-613.
49. Saito S, Umekage H, Nishidawa K, Morii T, Narita N, Enomoto M, Sakakura S, Harada N, Ichijo M, Morikawa H: Interleukin 4 (IL-4) blocks the IL-2-induced increase in natural killer activity and DNA synthesis of decidual CD16-CD56bright NK cells by inhibiting expression of the IL-2 receptor alpha, beta, and gamma. Cell Immunol 1996; 170:71-77.
50. Marzi M, Vigano A, Trabattoni D, Villa ML, Salvaggio A, Clerici E, et al.: Characterization of type 1 and type 2 cytokine production profile in physiologic and pathologic human pregnancy. Clin Exp Immunol 1996; 106:127-133.
51. Tezabwala BU, Johnson PM, Rees RC: Inhibition of pregnancy viability in mice after IL-2 administration. Immunology 1989; 67:115-120.
52. Chaouat G, Menu E, Clark DA, Dy M, Minkowshi M, Wegmann TG: Control of fetal survival in CBA×DBA/2 mice by lymphokine therapy. J Reprod Fertil 1990; 89:447-458.
53. Hunt JS, Atherton RA, Pace JL: Differential responses of rat trophoblast cells and embryonic fibroblasts to cytokines that regulate proliferation and class I MHC antigen expression. J Immunol 1990; 145:184-189.
54. Yui J, Garcia-Lloret M, Wegmann TG, Guilbert LJ: Cytotoxicity of tumor necrosis factor-alpha and gamma-interferon against primary human placental trophoblasts. Placenta 1994; 15:819-835.
55. Yui J, Hemmings D, Garcia-Lloret M, Guilbert LJ: Expression of the human p55 and p75 receptors in primary villous trophoblasts and their role in cytotoxic signal transduction. Biol Reprod 1996; 55:400-409.
56. Hunt JS, Chen HL, Miller L: Tumor necrosis factors: Pivotal components of pregnancy. Biol Reprod 1996; 54:554-562.
57. Wang Y, Walsh SW: TNF alpha concentrations and mRNA expression are increased in preeclamptic placentas. J Reprod Immunol 1996; 32:157-169.
58. Benyo DF, Miles TM, Conrad KP: Hypoxia stimulates cytokine production by villous explants from the human placenta. J Clin Endocrinol Metab 1997; 82:1582-1588.
59. Tangri S, Raghupathy R: Expression of cytokines in placentas of mice undergoing immunologically mediated spontaneous fetal resorptions. Biol Reprod 1993; 49:850-856.
60. Paulesu L, King A, Loke YW, Cintorino M, Bellizzi E, Boraschi D: Immunohistochemical localization of IL-1 alpha and IL-1 beta in normal human placenta. Lymphokine Cytokine Res 1991; 10:443-448.
61. Simon C, Frances A, Piquette G, Hendrickson M, Milki A, Polan ML: Interleukin-1 system in the materno-trophoblast unit in human implantation: immunohistochemical evidence for autocrine/paracrine function. J Clin Endocrinol Metab 1994; 78:847-854.
62. Masuhiro K, Matsuzaki N, Nishino E. Taniguchi T, Kameda T, Li T, et al.: Trophoblast-derived interleukin-1 (IL-1) stimulates the release of human chorionic gonadotropin by activating IL-6 and IL-6 receptor system in first trimester human trophoblast. J Clin Endocrinol Metab 1991; 72:594-601.
63. Steele GL, Currie WD, Leung EH, Yuen BH, Lueng PCK: Rapid stimulation of human chorionic gonadotropin secretion by interleukin-1 beta from perfused first trimester trophoblast. J Clin Endocrinol Metab 1992; 75:783-788.
64. Nestler JE: Interleukin-1 stimulates the aromatase activity of human placental cytotrophoblasts. Endocrinol 1993; 132:566-570.
65. Ishihara O, Khan H, Sullivan MHF, Elder MG: Interleukin-1 beta simulates decidual stromal cell cyclooxygenase enzyme and prostaglandin production. Prostaglandins 1992; 44:43-52.
66. Simon C, Frances A, Piquette GN, et al: Embryonic implantation in mice is blocked by interleukin-1 receptor antagonist. Endocrinology 1994; 134:521-528.